ML167 – 5 mg

Brand:
Cayman
CAS:
1285702-20-6
Storage:
-20
UN-No:
Non-Hazardous - /

The Cdc2-like kinases (Clks) and the dual-specificity tyrosine phosphorylation-regulated kinases (DYRKs) are involved in regulating gene splicing. Clks phosphorylate serine/arginine-rich proteins, which are a major component of the spliceosome, whereas DYRKs interact with and activate splicing factors. ML167 is a selective, ATP-competitive inhibitor of Clk4 with an IC50 value of 136 nM.{29292} It is more than 10-fold less active against the closely related kinases Clk1-3, DYRK1A, and DYRK1B (IC50s = 1.5, 1.6, >10, >10, and 4.4 µM, respectively), and minimally active against a panel of other kinases.{29292}  

 

Available on backorder

SKU: - Category:

Description

A selective, ATP-competitive inhibitor of Clk4 (IC50 = 136 nM)


Formal name: 5-[4-[[(5-methyl-2-furanyl)methyl]amino]-6-quinazolinyl]-2-furanmethanol

Synonyms:  CID 44968231

Molecular weight: 335.4

CAS: 1285702-20-6

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|Other Serine/Threonine Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Epigenetics, Transcription, & Translation|RNA, DNA, & Protein Synthesis